Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | GSR | P00390 | 2/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPY2R | P49146 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24030390 | 0.95 | TUBB4A (0.34) | GSRNPC1ALDH1A1LMNAMAPT | |
| SCHEMBL24030084 | 0.95 | PDE10A (0.33) | GSRPDE10ANPC1ALDH1A1LMNA | |
| SCHEMBL22425167 | 0.93 | PTGES (0.34) | GSRPDE10ANPC1ALDH1A1LMNA | |
| SCHEMBL21716227 | 0.92 | ESR1 (0.33) | ESR1ESR2GSRHPGD | |
| SCHEMBL24030317 | 0.91 | PTGES (0.35) | ESR1ESR2PTGES | |
| SCHEMBL21716872 | 0.91 | ESR1 (0.33) | ESR1ESR2GSRALDH1A1LMNA | |
| SCHEMBL24030104 | 0.91 | TUBB4A (0.36) | GSRPDE10ANPC1ALDH1A1LMNA | |
| SCHEMBL21716458 | 0.91 | ESR1 (0.34) | ESR1ESR2GSRPDE10AALDH1A1 | |
| SCHEMBL21168736 | 0.90 | KDM4E (0.35) | GSRPDE10ANPC1ALDH1A1LMNA | |
| SCHEMBL21168742 | 0.90 | KDM4E (0.35) | GSRPDE10ANPC1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LAS1L, ARL1, NAP1L4 | ESR1 18/4885ESR2 14/4885GSR 3942/4885 |
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | ESR1 69/4885ESR2 310/4885GSR 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.